Drug Type Small molecule drug |
Synonyms SCH 900271, SCH900271 |
Target |
Mechanism NIACR1 agonists(Hydroxycarboxylic acid receptor 2 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC14H16N2O4 |
InChIKeyARJKMWXLIHZLQZ-UHFFFAOYSA-N |
CAS Registry915210-50-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | SCH-900271 | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypercholesterolemia | Phase 2 | US | 03 Nov 2009 | |
Hyperlipidemia, Familial Combined | Phase 2 | - | 29 Jun 2009 | |
Primary hypercholesterolemia | Phase 2 | - | 29 Jun 2009 | |
Hyperlipidemias | Phase 2 | US | - |
Phase 2 | 619 | (SCH 900271 15 mg) | qxbpejrsev(dtbgshsbzy) = fxdffxwaku schrcfkkvx (rmufxlwmkl, nimqtotske - lsiexknsbi) View more | - | 12 Apr 2016 | ||
(SCH 900271 10 mg) | qxbpejrsev(dtbgshsbzy) = wfzkbahfoi schrcfkkvx (rmufxlwmkl, tbmjdlnipd - izwmasioyc) View more |